Treatment of Patients With Advanced Solid Tumors With Oral Agent ORIN1001 and in Combination With Standard of Care.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lin Shen, MD
Beijing Cancer Hospital and Peking University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beijing Cancer Hospital
Beijing, Beijing Municipality, China
- Jilin Cancer Hospital
Changchun, China
- the First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, China
- Harbin Medical University Cancer Hospital
Harbin, China
- Harbin Medical University Cancer Hospital
Heilongjiang, China
- the First Affiliated Hospital of Soochow University
Jiangse, China
- Harbin Medical University Cancer Hospital
Jilin City, China
- Shandong Provincial Cancer Hospital
Jinan, China
- Shandong Provincial Cancer Hospital
Shandong, China
- Shanghai Pulmonary Hospital
Shanghai, China
- the First Affiliated Hospital of Soochow University
Suzhou, China
- Tianjin Medical University Cancer Institute and Hospital
Tianjin, China
- the First Affiliated Hospital, Zhejiang University School of Medicine
Zhejiang, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jul 2020
- Primary completion
- 30 Jan 2023
- Completion
- 30 Jan 2025
- Last update posted
- 30 May 2025
- Registered enrollment
- 150
- Registry id
- NCT05154201
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.